Michelle Petri

Nov 19, 2024 | healio.com | Justin Cooper |Shenaz Bagha |Michelle Petri

Read more You've successfully added Lupus to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Oct 28, 2024 | healio.com | Justin Cooper |Shenaz Bagha |Michelle Petri

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Risks for miscarriage, preterm delivery and small for gestational age were greatest at the highest and lowest levels of vitamin D. The lowest risks were seen in the range of 40 ng/mL to 59 ng/mL.

Dec 19, 2023 | lupus.bmj.com | Aaron Bao |Michelle Petri |Andrea Fava |Jun Mo Kang

Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Aug 29, 2023 | acrjournals.onlinelibrary.wiley.com | Michelle Petri |Daniel Joyce |Kristin Haag |Andrea Fava

INTRODUCTION Both systemic lupus erythematosus (SLE) itself and the use of some immunosuppressants may impact the risk of COVID-19 (1-3). In particular, corticosteroids and B cell–depleting biologics such as rituximab impair vaccine response (4-6). SLE increases the risk of severe COVID-19 (hospitalization, intensive care unit stay, or intubation) both before and after vaccination (7).

Aug 17, 2023 | acrjournals.onlinelibrary.wiley.com | Michelle Petri |Daniel Joyce |Kristin Haag |Andrea Fava

No abstract is available for this article. Supporting Information Filename Description acr25109-sup-0001-Disclosureform.pdfPDF document, 1.8 MB Disclosure Form References 1, , , et al. Effect of systemic lupus erythematosus and immunosuppressive agents on COVID-19 vaccination antibody response. Arthritis Care Res (Hoboken) doi: https://doi.org/10.1002/acr.25094. 2023. E-pub ahead of print. 2, . COVID-19 in immunocompromised hosts: what we know so far.